Cyclobenzaprine is available in several strengths, including 5 mg, 7.5 mg, and 10 mg [1]. These strengths are formulated for oral administration, commonly as tablets [2].
What are the different forms of cyclobenzaprine?
Beyond immediate-release tablets, cyclobenzaprine is also available in a delayed-release formulation [3]. This formulation is designed to release the medication over a longer period, potentially offering different dosing schedules or efficacy profiles [3].
When does cyclobenzaprine patent protection end?
The patent landscape for cyclobenzaprine is complex due to its long history. The original patents have long expired, allowing for the availability of generic versions [4]. However, new patents may have been issued for specific formulations, such as the delayed-release version, or for novel uses of the drug [4]. Information on specific patent expiry dates for newer formulations can be found through resources like DrugPatentWatch.com [4].
How does cyclobenzaprine work?
Cyclobenzaprine is a muscle relaxant that works by acting on the central nervous system [5]. It is believed to reduce muscle spasms by decreasing involuntary skeletal muscle activity, although its exact mechanism is not fully understood [5]. It is not considered a direct-acting skeletal muscle relaxant [5].
What are common side effects of cyclobenzaprine?
Common side effects associated with cyclobenzaprine use include drowsiness, dry mouth, dizziness, and fatigue [6]. Patients are advised to use caution when driving or operating machinery due to potential drowsiness [6].
What conditions is cyclobenzaprine used to treat?
Cyclobenzaprine is prescribed to relieve muscle spasms associated with acute, painful musculoskeletal conditions [7]. It is typically used as an adjunct to rest and physical therapy [7].